Prevalence of Age-Associated Testosterone Deficiency Syndrome in Indian Population.

IF 1.8 Q3 UROLOGY & NEPHROLOGY
Advances in Urology Pub Date : 2019-03-20 eCollection Date: 2019-01-01 DOI:10.1155/2019/2468926
Ghanendra Kumar Yadav, Mrinal Pahwa, Mahendra Singh, Vipin Tyagi, Sudhir Chadha
{"title":"Prevalence of Age-Associated Testosterone Deficiency Syndrome in Indian Population.","authors":"Ghanendra Kumar Yadav,&nbsp;Mrinal Pahwa,&nbsp;Mahendra Singh,&nbsp;Vipin Tyagi,&nbsp;Sudhir Chadha","doi":"10.1155/2019/2468926","DOIUrl":null,"url":null,"abstract":"<p><p>Testosterone deficiency syndrome (TDS) is a gradual age-related phenomenon that occurs in a large proportion of the aging male population. This current prospective study was done with the objective to estimate the prevalence of age-associated TDS in India and its clinical profile. A total of 800 male patients aged ≥40 year were approached to participate in the study. A brief history and focused examination was done. Based on our exclusion criteria, 55 patients were excluded. Androgen deficiency in aging male (ADAM) questionnaire was administered to all remaining 745 patients. Out of these 745 patients, ADAM-positive (symptomatic TDS) patients were found to be 359 and enrolled in the study. In all ADAM-positive patients, serum testosterone levels were measured. Prevalence of symptomatic TDS in study population was found to be 48.18%. Mean total and free testosterone level of symptomatic TDS population were 3.287 ± 1.494 ng/ml (1.12-9.61) and 7.476 ± 2.902 pg/ml (2.18-21.76), respectively. Prevalence of biochemically confirmed TDS among symptomatic TDS population was 60.17%. Prevalence of TDS increases progressively with each decade of life (<i>p</i>=0.034). Prevalence was higher in patients with diabetes, hypertension, coronary artery disease, obesity, and metabolic syndrome. TDS is a real phenomenon with a prevalence of 28.99% in our study population.</p>","PeriodicalId":7490,"journal":{"name":"Advances in Urology","volume":"2019 ","pages":"2468926"},"PeriodicalIF":1.8000,"publicationDate":"2019-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/2468926","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/2468926","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Testosterone deficiency syndrome (TDS) is a gradual age-related phenomenon that occurs in a large proportion of the aging male population. This current prospective study was done with the objective to estimate the prevalence of age-associated TDS in India and its clinical profile. A total of 800 male patients aged ≥40 year were approached to participate in the study. A brief history and focused examination was done. Based on our exclusion criteria, 55 patients were excluded. Androgen deficiency in aging male (ADAM) questionnaire was administered to all remaining 745 patients. Out of these 745 patients, ADAM-positive (symptomatic TDS) patients were found to be 359 and enrolled in the study. In all ADAM-positive patients, serum testosterone levels were measured. Prevalence of symptomatic TDS in study population was found to be 48.18%. Mean total and free testosterone level of symptomatic TDS population were 3.287 ± 1.494 ng/ml (1.12-9.61) and 7.476 ± 2.902 pg/ml (2.18-21.76), respectively. Prevalence of biochemically confirmed TDS among symptomatic TDS population was 60.17%. Prevalence of TDS increases progressively with each decade of life (p=0.034). Prevalence was higher in patients with diabetes, hypertension, coronary artery disease, obesity, and metabolic syndrome. TDS is a real phenomenon with a prevalence of 28.99% in our study population.

Abstract Image

Abstract Image

年龄相关性睾酮缺乏综合征在印度人群中的患病率。
睾酮缺乏综合征(TDS)是一种逐渐与年龄相关的现象,发生在很大比例的老年男性人群中。本前瞻性研究的目的是估计印度年龄相关TDS的患病率及其临床概况。共有800名年龄≥40岁的男性患者被纳入研究。做了简单的病史和重点检查。根据我们的排除标准,55例患者被排除在外。其余745例患者进行老年男性雄激素缺乏问卷调查。在这745名患者中,有359名adam阳性(有症状的TDS)患者被纳入研究。在所有adam阳性患者中,测量血清睾酮水平。研究人群中有症状的TDS患病率为48.18%。有症状TDS人群平均总睾酮和游离睾酮水平分别为3.287±1.494 ng/ml(1.12-9.61)和7.476±2.902 pg/ml(2.18-21.76)。症状性TDS人群中生化确诊TDS患病率为60.17%。TDS患病率随着寿命的增加而逐渐增加(p=0.034)。糖尿病、高血压、冠状动脉疾病、肥胖和代谢综合征患者的患病率较高。TDS是一种真实的现象,在我们的研究人群中患病率为28.99%。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advances in Urology
Advances in Urology UROLOGY & NEPHROLOGY-
CiteScore
2.90
自引率
0.00%
发文量
17
审稿时长
15 weeks
期刊介绍: Advances in Urology is a peer-reviewed, open access journal that publishes state-of-the-art reviews and original research papers of wide interest in all fields of urology. The journal strives to provide publication of important manuscripts to the widest possible audience worldwide, without the constraints of expensive, hard-to-access, traditional bound journals. Advances in Urology is designed to improve publication access of both well-established urologic scientists and less well-established writers, by allowing interested scientists worldwide to participate fully.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信